I-Nicotinamide mononucleotide powder ividiyo
Nmn powder Base Ulwazi
igama |
Umgubo we-NMN |
CAS |
1094-61-7 |
Ukungcola |
98% |
Igama leKhemikhali |
I-beta-Nicotinamide mononucleotide
I-nicotinamide mononucleotide
1094-61-7
beta-NMN
Inicotinamide iribonucleotide |
Iintetho ezifanayo |
I-3-Carbamoyl-1- [5-O- (hydroxyphosphinato) -β-D-ribofuranosyl] pyridinium |
I-Molecular Formula |
C11H15N2O8P |
Isisindo somzimba |
334.221 g / mol |
Indawo yokunyibilika |
> 96 ° C |
InChI Key |
I-DAYLJWODMCOQEW-TURQNECASA-N |
imo |
solid |
Kubonakala |
umgubo omhlophe |
Ubomi obulicla |
|
Umzimba |
inyibilika emanzini |
yoGcino Imeko |
I-Hygroscopic, -20˚C Ifreezer, phantsi kwe-Inert atmosphere |
isicelo |
I-Nicotinamide mononucleotide ("NMN", "NAMN", kunye ne "β-NMN") yi-nucleotide ethathwe kwi-ribose kunye ne-nicotinamide. |
UXwebhu loVavanyo |
iyafumaneka |
Nmn powder Inkcazo ngokubanzi
i-beta-Nicotinamide i-mononucleotide powder (1094-61-7) iyimveliso ye-extracellular Nicotinamide phosphoribosyltransferase (eNAMPT) yokusabela kunye nesitshixo esiphambili seNAD +. Kukunyamezelela i-glucose ukunganyamezeli ngokubuyisela amanqanaba e-NAD + kwiimpazamo ze-T2D ezine-TXNUMXD.
Ukonyusa ukuziva kwe-hepatic insulin kunye nokubuyisela ukubonakaliswa kohlobo olunxulumene noxinzelelo lwe-oxidative, impendulo yokuvuvukala, kunye nesigqi se-circadian, ngokuyinxalenye ngokusebenza kwe-SIRT1.
I-Nmn powder (1094-61-7) Imbali
I-Beta-Nicotinamide mononucleotide (NMN) ipowder iphakathi kwe-NAD + biosynthesis eveliswe kwi-nicotinamide nge-nicotinamide phosphoribosyltransferase (NAMPT) ekwabizwa ngokuba yi-NMN okanye i-nicotinamide ribotide. Kwizifundo zamva nje zezicelo ze-NMN kuthintelo kunye nokuchongwa kwezifo ezixhomekeke kubudala ezinje ngesifo seswekile, isifo se-neurodegenerative, isifo sentliziyo njlnjl., Iye yaba yenye yezona zinto zishushu kakhulu kwingxoxo yokulwa ukuguga, mva nje.
I-Nmn powder Mechanism of Action
I-beta-Nicotinamide mononucleotide (β-NMN) sisandulela se-biosynthetic ye-nicotinamide adenine dinucleotide (NAD +) eyaziwayo ukukhuthaza imveliso yeselula ye-NAD + kunye nokuchasene nezifo ezinxulumene nobudala ezinxulumene nokuhla kwamanqanaba eNAD +.
Nmn powder (1094-61-7) Isicelo
Iiseli eziguga. Ewe kunjalo, umsebenzi odlulileyo kwilebhu ye-Imai ubonakalisile ukuba ukunika i-beta-Nicotinamide mononucleotide kwiimpuku ezindala kunefuthe elihle kwimetabolism emzimbeni wonke, kubandakanya neziphumo ezihle kwimisipha yamathambo, ukusebenza kwesibindi, ukuxinana kwethambo, ukusebenza kwamehlo, uvakalelo lwe-insulin, ukusebenza komzimba ubunzima, kunye nenqanaba lomsebenzi.
Nmn powder (1094-61-7) Olunye uphando
Iiseli eziguga. Ewe kunjalo, umsebenzi odlulileyo kwilebhu ye-Imai ubonakalisile ukuba ukunika i-beta-Nicotinamide mononucleotide kwiimpuku ezindala kunefuthe elihle kwimetabolism emzimbeni wonke, kubandakanya neziphumo ezihle kwimisipha yamathambo, ukusebenza kwesibindi, ukuxinana kwethambo, ukusebenza kwamehlo, uvakalelo lwe-insulin, ukusebenza komzimba ubunzima, kunye nenqanaba lomsebenzi.
Umgubo weNmn (1094-61-7) Reference
- 1, iBogan, KL; IBrenner, C (2008). "I-Nicotinic acid, i-nicotinamide, kunye ne-nicotinamide riboside: uvavanyo lweemolekyuli ze-NAD + zandulela iivithamini kwisondlo sabantu". Uphengululo lonyaka lweZondlo. 28: 115-30. ikhonkco: 10.1146 / annurev.nutr.28.061807.155443. IINKCUKACHA:
- 2, IBrazil, JM; Li, C; Zhu, Y; IZhai, RG (kaJuni 2017). “I-NMNAT: Sisenzo esiyi-NAD +… Sisisithethi… Yi-neuroprotector”. Uluvo lwangoku kwiGenetics noPhuhliso. 44: 156-162. ikhonkco: 10.1016 / j.gde.2017.03.014. I-PMID 5515290.
- I-3, "uLawulo lwexesha elide lweNicotinamide Mononucleotide Mitigates Ukwehla okunxulumene nePhysiological Age kwiimpuku". Iseli Metabolism. 13 ngoDisemba 2016.
- 4, Stipp, David (Matshi 11, 2015). "Ngaphandle kweResveratrol: Inkqubo yokuChasana nokuguga yeNAD". Inethiwekhi yeNzululwazi yaseMelika.
- Yonke into ekufuneka uyazi ngeNicotinamide Riboside Chloride
- I-Nicotinamide Mononucleotide (NMN): Izibonelelo, iidosi, isongezelelo, uphando